Krūts vēža problēma
Breast cancer is a common female malignant tumor that seriously threatens the physical and mental health of women, so it is also known as the “red killer”. Statistics show that breast cancer causes 458,000 deaths each year, and its incidence is increasing worldwide. In recent years, the incidence of breast cancer in India has risen rapidly, and there is a trend of youth. Breast cancer has become the most common cancer among Indian women. The number of new breast cancers and deaths in India each year account for 12.2% and 9.6% of the world’s total.
Krūts vēža ārstēšana
Breast cancer is not terrible. Breast cancer treatment has achieved rapid progress. Breast cancer is one of the best treatments for breast cancer. According to statistics, the five-year survival rate for breast cancer in the United States is 89%, and the five-year survival rate for breast cancer patients in China is 73.1%. We can treat breast cancer as a chronic disease, not a terminal illness.
The treatment of breast cancer is mainly surgery + chemotherapy or radiotherapy. The conventional treatment is to remove the tumor lesion as much as possible. After the operation, radiotherapy and chemotherapy are used to kill the residual tumor cells and prevent tumor recurrence. However, scientific research shows that not all breast cancer patients need chemotherapy, and chemotherapy is not useful for some breast cancer patients. Unwanted chemotherapy also kills a large number of normal human cells, which is extremely harmful to women. Breast cancer gene tests invented by American scientists can help breast cancer patients avoid unnecessary chemotherapy. The occurrence, development, and metastasis of breast cancer are related to gene mutations. Breast cancer 21 gene testing can find these mutant genes, predict the probability of breast cancer patients’ recurrence, and help breast cancer patients choose or avoid chemotherapy. The whole-gene cancer test can screen targeted drugs to treat this mutation, to achieve the largest curative effect and the smallest toxic and side effects, and to achieve precise personalized treatment.
Ģenētiskā pārbaude krūts vēža gadījumā
Breast 21 oncogene testing can help doctors and patients decide on the best treatment options. Through the 21-gene test, observe the interaction between genes to determine the characteristics of the tumor, so as to predict the probability of breast cancer recurrence and the probability of possible benefit from chemotherapy. In other words, patients can know whether their breast cancer will recur through genetic testing, the probability of recurrence, determine whether breast cancer patients need postoperative chemotherapy, and how to avoid excessive chemotherapy. In order to determine more effective treatment options for breast cancer patients, to achieve sophisticated individualized treatment.
Breast cancer 21 gene test is beneficial for patients with early estrogen receptor positive (ER +), negative lymph node metastasis, and newly diagnosed breast cancer patients who will be treated with tamoxifen. It can predict the probability of breast cancer recurrence and the possibility of chemotherapy Benefit probability. After menopause, lymph node-positive and estrogen receptor-positive invasive breast cancer patients can also be genetically tested to determine whether the patient needs chemotherapy.
In recent years, through genetic testing to guide precise treatment, the 5-year survival rate and long-term survival rate of breast cancer patients have greatly improved. Breast cancer has become one of the solid tumors with the best curative effect.
